Risk factor prediction and immune correlation analysis of cuproptosis-related gene in osteoarthritis
View abstract on PubMed
Summary
This summary is machine-generated.Cuproptosis-related genes (CRGs) are linked to osteoarthritis (OA) progression. Nine key CRGs show potential as diagnostic biomarkers for this widespread inflammatory joint disease.
Area Of Science
- Biochemistry
- Cell Biology
- Genetics
Background
- Osteoarthritis (OA) is a prevalent inflammatory joint disease causing significant global disability.
- Cuproptosis, a novel cell death pathway, plays a role in OA pathogenesis.
- Identifying reliable biomarkers for OA diagnosis and treatment is crucial.
Purpose Of The Study
- To investigate the relationship between cuproptosis-related genes (CRGs) and OA.
- To evaluate the diagnostic and therapeutic potential of CRGs in OA.
Main Methods
- Analysis of differential gene expression in OA datasets from GEO databases.
- Identification of key CRGs using bioinformatics and logistic regression.
- Validation of gene expression using RT-PCR and in vitro experiments on chondrocytes.
Main Results
- Ten key CRGs were identified, with nine showing significant differential expression in OA models.
- Two distinct CRG expression patterns were observed, with one correlating with OA progression.
- In vitro studies confirmed altered CRG expression in response to inflammatory stimuli and cuproptosis inducers, exacerbating chondrocyte apoptosis.
Conclusions
- The identified nine CRGs are significantly associated with OA.
- These CRGs demonstrate potential as diagnostic biomarkers for osteoarthritis.
- Targeting CRGs may offer new therapeutic strategies for OA treatment.

